Evaluating the effects of the novel GLP-I analogue, liraglutide, in patients with Alzherimer's disease (ELAD Study) - Open Label Extension

Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Principal Investigator Last Name
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
Funding Organization
Agency/Funding Organization
Funding Organization Country